Please login to the form below

Not currently logged in
Email:
Password:

subcutaneous injection

This page shows the latest subcutaneous injection news and features for those working in and with pharma, biotech and healthcare.

Janssen’s Stelara approved by FDA for psoriatic arthritis in paediatric patients

Janssen’s Stelara approved by FDA for psoriatic arthritis in paediatric patients

The treatment is administered as a subcutaneous injection four times per year after two starter doses for the treatment of paediatric patients aged six years and older with active PsA.

Latest news

More from news
Approximately 1 fully matching, plus 97 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    It’s given as a subcutaneous injection that takes less than a minute to deliver every two weeks, around 75% fewer injections than other products for HAE prevention. ... Injection volumes are lower, it can be taken weekly as well as monthly and can be

  • Implementing eHealth innovation Implementing eHealth innovation

    Growth hormone treatment (GHT) is only available on prescription and is given as a subcutaneous injection (directly under the skin). ... complete, partial, missed) of each injection, and uploads this data wirelessly from the patients’ homes to the

  • Deal Watch November 2016 Deal Watch November 2016

    Arsia has a proprietary viscosity reducing technology and know-how to enable the development of high concentration formulations of biologics that can be administered by subcutaneous injection rather than intravenously. ... Invossa, cell-mediated gene

  • Deal Watch July 2016 Deal Watch July 2016

    cells. The product has been submitted to the EMA following a phase III trial showing safety and efficacy of a single injection in the treatment of complex peri-anal fistulas, and ... The presentation is subcutaneous injection in both indications, leaving

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    At the moment, biologics are generally delivered by intravenous or subcutaneous injection, which is effective but not desirable for patients, particularly for chronic conditions.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
The Difference Collective

Welcome to the Difference Collective – a healthcare communications team of 80+ talented experts who Deliver Differently. We’re purpose-built around...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...